BioCentury | Jul 26, 2019
Preclinical News
July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more
...Israel). Cytokinetics’ CK-2066260 could improve muscle performance Researchers at Karolinska Institutet, Cytokinetics Inc (NASDAQ:CYTK) and University of Missouri...